Steve Silver

Stock Analyst at Argus Research

(0.22)

# 4,409

Out of 5,099 analysts

3

Total ratings

33.33%

Success rate

-29.03%

Average return

Main Sectors:

Top Industries:

Medical Devices Drug Manufacturers - Specialty & Generic

Stocks Rated by Steve Silver

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	DXCM DexCom	Maintains: Buy	$100 → $90	$67.56	+33.21%	2	Nov 7, 2025
	FLGC Flora Growth	Maintains: Buy	$2,340	$9.61	+24,249.64%	1	Feb 1, 2023

DexCom

Nov 7, 2025

Maintains: Buy

Price Target: $100 → $90

Current: $67.56

Upside: +33.21%

Flora Growth

Feb 1, 2023

Maintains: Buy

Price Target: $2,340

Current: $9.61

Upside: +24,249.64%